特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

組織診断の世界市場:製品、技術、用途、エンドユーザー、および地域別の予測 (2020-2027年)

Global Tissue Diagnostics Market Size study, by Product, Technology, by Application, by End-User and Regional Forecasts 2020-2027

発行 Bizwit Research & Consulting LLP 商品コード 939896
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=106.59円で換算しております。
組織診断の世界市場:製品、技術、用途、エンドユーザー、および地域別の予測 (2020-2027年) Global Tissue Diagnostics Market Size study, by Product, Technology, by Application, by End-User and Regional Forecasts 2020-2027
出版日: 2020年05月01日 ページ情報: 英文
概要

世界の組織診断市場規模は、2019年に約32億米ドルとなり、2020年から2027年の予測期間中、6.5%以上の成長率で拡大すると予測されています。組織診断は、主に針吸引細胞診、コア生検、オープン生検によって行われます。組織診断のこれらの技術と機器の進歩は、組織に関連する疾患の迅速かつ正確な決定と評価に役立ちます。さらに、自動化された組織診断システムの高い導入率、高齢化人口の増加による癌の発生率の増加、および世界的なヘルスケアコストの上昇などは、予測期間中の高いCAGRの要因となっています。国際がん研究機関(IARC)によると、2018年には世界中で約1700万件の新しいがん症例と950万件のがん死が報告されました。また、2040年までに新たに2750万件のがん症例と1630万件のがんによる死亡が予測されています。がん有病率の上昇に伴い、組織診断の採用および有効性は世界中で拡大すると予測されています。

当レポートでは、世界の組織診断市場について調査し、市場の概要、製品、技術、アプリケーション、エンドユーザーおよび地域別による市場の分析と予測、競合情勢の分析、主要企業のプロファイルなどを提供しています。

第1章 エグゼクティブサマリー

第2章 世界の組織診断市場の定義と範囲

第3章 世界の組織診断市場のダイナミクス

  • 影響分析

第4章 業界分析

  • ポーターのファイブフォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの提言と結論

第5章 世界の組織診断市場:製品別

  • 市場スナップショット
  • 潜在性分析
  • 市場推計・予測: 製品別
  • サブセグメント分析
    • 消耗品
    • 装置

第6章 世界の組織診断市場:技術別

  • 市場スナップショット
  • 潜在性分析
  • 市場推計・予測:技術別
  • サブセグメント分析
    • 免疫組織染色 (IHC)
    • in situ ハイブリダイゼーション (ISH)
    • デジタル病理学・ワークフロー管理
    • 特殊染色法

第7章 世界の組織診断市場:アプリケーション別

  • 市場スナップショット
  • 潜在性分析
  • 市場推計・予測: アプリケーション別
  • サブセグメント分析
    • 乳癌
    • 胃癌
    • 前立腺癌
    • リンパ腫
    • 非小細胞肺癌(NSCLC)
    • その他

第8章 世界の組織診断市場:エンドユーザー別

  • 市場スナップショット
  • 潜在性分析
  • 市場推計・予測: エンドユーザー別
  • サブセグメント分析
    • 病院
    • 研究所
    • 医薬品企業
    • CRO
    • その他

第9章 世界の組織診断市場:地域分析

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州のスナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋のスナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカのスナップショット
    • ブラジル
    • メキシコ
  • その他の地域

第10章 競合情報

  • 主な市場戦略
  • 企業プロファイル
    • F. Hoffmann-La Roche AG
    • Danaher Corporation
    • Thermo Fisher Scientific
    • Abbott Laboratories
    • Agilent Technologies
    • Merck KGaA
    • Sakura Finetek Japan Co.,Ltd.
    • Becton, Dickinson and Company
    • Bio-Genex Laboratories
    • Hologic, Inc.

第11章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. GLOBAL TISSUE DIAGNOSTICS MARKET, REPORT SCOPE
  • TABLE 2. GLOBAL TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY REGION 2017-2027 (USD BILLION)
  • TABLE 3. GLOBAL TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY PRODUCT 2017-2027 (USD BILLION)
  • TABLE 4. GLOBAL TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY TECHNOLOGY 2017-2027 (USD BILLION)
  • TABLE 5. GLOBAL TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY APPLICATION 2017-2027 (USD BILLION)
  • TABLE 6. GLOBAL TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY END-USER 2017-2027 (USD BILLION)
  • TABLE 7. GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 8. GLOBAL TISSUE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 9. GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 10. GLOBAL TISSUE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 11. GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 12. GLOBAL TISSUE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 13. GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 14. GLOBAL TISSUE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 15. GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 16. GLOBAL TISSUE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 17. U.S. TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 18. U.S. TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 19. U.S. TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 20. CANADA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 21. CANADA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 22. CANADA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 23. UK TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 24. UK TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 25. UK TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 26. GERMANY TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 27. GERMANY TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 28. GERMANY TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 29. ROE TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 30. ROE TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 31. ROE TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 32. CHINA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 33. CHINA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 34. CHINA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 35. INDIA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 36. INDIA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 37. INDIA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 38. JAPAN TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 39. JAPAN TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 40. JAPAN TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 41. ROAPAC TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 42. ROAPAC TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 43. ROAPAC TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 44. BRAZIL TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 45. BRAZIL TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 46. BRAZIL TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 47. MEXICO TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 48. MEXICO TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 49. MEXICO TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 50. ROLA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 51. ROLA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 52. ROLA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 53. ROW TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 54. ROW TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 55. ROW TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 56. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL TISSUE DIAGNOSTICS MARKET
  • TABLE 57. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL TISSUE DIAGNOSTICS MARKET
  • TABLE 58. YEARS CONSIDERED FOR THE STUDY
  • TABLE 59. EXCHANGE RATES CONSIDERED

LIST OF FIGURES

  • FIG 1. GLOBAL TISSUE DIAGNOSTICS MARKET, RESEARCH METHODOLOGY
  • FIG 2. GLOBAL TISSUE DIAGNOSTICS MARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. GLOBAL TISSUE DIAGNOSTICS MARKET, KEY TRENDS 2019
  • FIG 5. GLOBAL TISSUE DIAGNOSTICS MARKET, GROWTH PROSPECTS 2020-2027
  • FIG 6. GLOBAL TISSUE DIAGNOSTICS MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. GLOBAL TISSUE DIAGNOSTICS MARKET, PEST ANALYSIS
  • FIG 8. GLOBAL TISSUE DIAGNOSTICS MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
  • FIG 10. GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
  • FIG 11. GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
  • FIG 12. GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
  • FIG 13. GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
  • FIG 14. GLOBAL TISSUE DIAGNOSTICS MARKET, REGIONAL SNAPSHOT 2017 & 2027
  • FIG 15. NORTH AMERICA TISSUE DIAGNOSTICS MARKET 2017 & 2027 (USD BILLION)
  • FIG 16. EUROPE TISSUE DIAGNOSTICS MARKET 2017 & 2027 (USD BILLION)
  • FIG 17. ASIA PACIFIC TISSUE DIAGNOSTICS MARKET 2017 & 2027 (USD BILLION)
  • FIG 18. LATIN AMERICA TISSUE DIAGNOSTICS MARKET 2017 & 2027 (USD BILLION)
  • FIG 19. GLOBAL TISSUE DIAGNOSTICS MARKET, COMPANY MARKET SHARE ANALYSIS (2019)
目次

Global Tissue Diagnostics Market is valued approximately USD 3.2 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 6.5% over the forecast period 2020-2027. Tissue diagnostics is rapidly serving as the gold standards for diagnosis of cancer. Tissue diagnostics is a type of technique used in removal of tissue from the patient's body, which is then processed, tested and analyzed under the microscope to perceive the diseases, such as cancer. Tissue diagnostics is primarily performed by needle aspiration cytology, core biopsy and open biopsy. The advancements in these techniques and equipment of tissue diagnostics helps in quick and precise determination and evaluation of diseases associated to the tissues. Further, high adoption of automated tissue diagnostics system, increasing incidences of cancer owing to growing aging population, and rise in healthcare expenditure across the globe are the few factors responsible for high CAGR of the market during the forecast period. As per the International Agency for Research on Cancer (IARC), around 17.0 million new cancer cases and 9.5 million cancer deaths were totaled in 2018 worldwide. Also, it is predicted that it would grow to almost 27.5 million new cancer cases and 16.3 million cancer deaths by 2040. With the rise in prevalence of cancer, the adoption & utility for tissue diagnostics is likely to grow around the world. Moreover, the outbreak of COVID-19 around the world stressed a major concern on the governments of all COVID-19 hit nations. Since, there is an excruciating need to test and screen a large number of patients for possible Sars-Cov-2 infection. As a result, most of the nations are facing a major shortage in the supply for diagnostic kits to test this virus. Therefore, tissue diagnostics virology suppliers are under immense pressure to deliver reliable testing kits, and therefore, there is a surge in demand for tissue diagnostics systems worldwide. However, high degree of consolidation and budget constraints are the factors impeding the growth of market over the forecast period of 2020-2027.

The regional analysis of global Tissue Diagnostics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to increasing number of patients with COVID-19 infections, along with the ongoing advancements in the field of gene & immunoassay-based products in the region. Whereas, Asia-Pacific is anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027. Factors such as rising elderly population, rising cases of cancer and improving healthcare infrastructure would create lucrative growth prospects for the tissue diagnostics market across Asia-Pacific region.

Major market player included in this report are:

F. Hoffmann-La Roche AG

Danaher Corporation

Thermo Fisher Scientific

Abbott Laboratories

Agilent Technologies

Merck KGaA

Sakura Finetek Japan Co., Ltd.

Becton, Dickinson and Company

Bio-Genex Laboratories

Hologic, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Consumables

Instruments

By Technology:

Immunohistochemistry (IHC)

In Situ Hybridization (ISH)

Digital Pathology and Workflow Management

Special Staining

By Application:

Breast Cancer

Gastric Cancer

Prostate Cancer

Lymphoma

Non-Small Cell Lung Cancer (NSCLC)

Others

By End-User:

Hospitals

Research Laboratories

Pharmaceutical Companies

Contract Research Organizations

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2017, 2018

Base year - 2019

Forecast period - 2020 to 2027

Target Audience of the Global Tissue Diagnostics Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
    • 1.2.1. Tissue Diagnostics Market, by Region, 2018-2027 (USD Billion)
    • 1.2.2. Tissue Diagnostics Market, by Product, 2018-2027 (USD Billion)
    • 1.2.3. Tissue Diagnostics Market, by Technology, 2018-2027 (USD Billion)
    • 1.2.4. Tissue Diagnostics Market, by Application, 2018-2027 (USD Billion)
    • 1.2.5. Tissue Diagnostics Market, by End-User, 2018-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Tissue Diagnostics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Tissue Diagnostics Market Dynamics

  • 3.1. Tissue Diagnostics Market Impact Analysis (2018-2027)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Tissue Diagnostics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2017-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Tissue Diagnostics Market, by Product

  • 5.1. Market Snapshot
  • 5.2. Global Tissue Diagnostics Market by Product, Performance - Potential Analysis
  • 5.3. Global Tissue Diagnostics Market Estimates & Forecasts by Product 2017-2027 (USD Billion)
  • 5.4. Tissue Diagnostics Market, Sub Segment Analysis
    • 5.4.1. Consumables
    • 5.4.2. Instruments

Chapter 6. Global Tissue Diagnostics Market, by Technology

  • 6.1. Market Snapshot
  • 6.2. Global Tissue Diagnostics Market by Technology, Performance - Potential Analysis
  • 6.3. Global Tissue Diagnostics Market Estimates & Forecasts by Technology 2017-2027 (USD Billion)
  • 6.4. Tissue Diagnostics Market, Sub Segment Analysis
    • 6.4.1. Immunohistochemistry (IHC)
    • 6.4.2. In Situ Hybridization (ISH)
    • 6.4.3. Digital Pathology and Workflow Management
    • 6.4.4. Special Staining

Chapter 7. Global Tissue Diagnostics Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Tissue Diagnostics Market by Application - Potential Analysis
  • 7.3. Global Tissue Diagnostics Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
  • 7.4. Tissue Diagnostics Market, Sub Segment Analysis
    • 7.4.1. Breast Cancer
    • 7.4.2. Gastric Cancer
    • 7.4.3. Prostate Cancer
    • 7.4.4. Lymphoma
    • 7.4.5. Non-Small Cell Lung Cancer (NSCLC)
    • 7.4.6. Others

Chapter 8. Global Tissue Diagnostics Market, by End-User

  • 8.1. Market Snapshot
  • 8.2. Global Tissue Diagnostics Market by End-User - Potential Analysis
  • 8.3. Global Tissue Diagnostics Market Estimates & Forecasts by End-User 2017-2027 (USD Billion)
  • 8.4. Tissue Diagnostics Market, Sub Segment Analysis
    • 8.4.1. Hospitals
    • 8.4.2. Research Laboratories
    • 8.4.3. Pharmaceutical Companies
    • 8.4.4. Contract Research Organizations
    • 8.4.5. Others

Chapter 9. Global Tissue Diagnostics Market, Regional Analysis

  • 9.1. Tissue Diagnostics Market, Regional Market Snapshot
  • 9.2. North America Tissue Diagnostics Market
    • 9.2.1. U.S. Tissue Diagnostics Market
      • 9.2.1.1. Product breakdown estimates & forecasts, 2017-2027
      • 9.2.1.2. Technology breakdown estimates & forecasts, 2017-2027
      • 9.2.1.3. Application breakdown estimates & forecasts, 2017-2027
      • 9.2.1.4. End-User breakdown estimates & forecasts, 2017-2027
    • 9.2.2. Canada Tissue Diagnostics Market
  • 9.3. Europe Tissue Diagnostics Market Snapshot
    • 9.3.1. U.K. Tissue Diagnostics Market
    • 9.3.2. Germany Tissue Diagnostics Market
    • 9.3.3. France Tissue Diagnostics Market
    • 9.3.4. Spain Tissue Diagnostics Market
    • 9.3.5. Italy Tissue Diagnostics Market
    • 9.3.6. Rest of Europe Tissue Diagnostics Market
  • 9.4. Asia-Pacific Tissue Diagnostics Market Snapshot
    • 9.4.1. China Tissue Diagnostics Market
    • 9.4.2. India Tissue Diagnostics Market
    • 9.4.3. Japan Tissue Diagnostics Market
    • 9.4.4. Australia Tissue Diagnostics Market
    • 9.4.5. South Korea Tissue Diagnostics Market
    • 9.4.6. Rest of Asia Pacific Tissue Diagnostics Market
  • 9.5. Latin America Tissue Diagnostics Market Snapshot
    • 9.5.1. Brazil Tissue Diagnostics Market
    • 9.5.2. Mexico Tissue Diagnostics Market
  • 9.6. Rest of The World Tissue Diagnostics Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. F. Hoffmann-La Roche AG
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Danaher Corporation
    • 10.2.3. Thermo Fisher Scientific
    • 10.2.4. Abbott Laboratories
    • 10.2.5. Agilent Technologies
    • 10.2.6. Merck KGaA
    • 10.2.7. Sakura Finetek Japan Co.,Ltd.
    • 10.2.8. Becton, Dickinson and Company
    • 10.2.9. Bio-Genex Laboratories
    • 10.2.10. Hologic, Inc.

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption